| - GRCh38:
- Chr16:21936825-22429665
| LOC130058641, SDR42E2, TRL-AAG2-4, TRL-TAG3-1, UQCRC2, VWA3A, LOC130058642, LOC130058643, LOC132090373, MOSMO, PDZD9, POLR3E, LOC130058644, LOC130058645, LOC130058646, CDR2, CDR2-DT, EEF2K, LOC105371129, LOC111562378, LOC121587534, LOC125146427, LOC125146428, LOC126862313, LOC130058628, LOC130058629, LOC130058630, LOC130058631, LOC130058632, LOC130058633, LOC130058634, LOC130058635, LOC130058636, LOC130058637, LOC130058638, LOC130058639, LOC130058640 | | Chromosome 16p12.1 deletion syndrome, 520kb | Pathogenic (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21747532-22824584
| CDR2, EEF2K, MOSMO, NPIPB4, NPIPB5, OTOA, PDZD9, POLR3E, SDR42E2, UQCRC2, VWA3A | | Chromosome 16p12.1 deletion syndrome, 520kb | Pathogenic (Nov 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21869250-22524572
| CDR2, EEF2K, MOSMO, NPIPB4, PDZD9, POLR3E, SDR42E2, UQCRC2, VWA3A | | Chromosome 16p12.1 deletion syndrome, 520kb | Pathogenic (Nov 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21781158-22825913
| CDR2, EEF2K, HS3ST2, MOSMO, NPIPB4, NPIPB5, PDZD9, POLR3E, SDR42E2, UQCRC2, VWA3A | | Chromosome 16p12.1 deletion syndrome, 520kb | Pathogenic (Sep 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21964695-22376385
| CDR2, EEF2K, MOSMO, PDZD9, POLR3E, SDR42E2, UQCRC2, VWA3A | | Chromosome 16p12.1 deletion syndrome, 520kb | Pathogenic (Oct 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21973828-22361172
| CDR2, EEF2K, MOSMO, PDZD9, POLR3E, SDR42E2, UQCRC2, VWA3A | | Chromosome 16p12.1 deletion syndrome, 520kb | Likely pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21964083-22386845
| CDR2, EEF2K, MOSMO, PDZD9, POLR3E, SDR42E2, UQCRC2, VWA3A | | Chromosome 16p12.1 deletion syndrome, 520kb | Pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21973828-22361172
| CDR2, EEF2K, UQCRC2, VWA3A, PDZD9, POLR3E, MOSMO, SDR42E2 | | Chromosome 16p12.1 deletion syndrome, 520kb | Likely pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21976691-22386881
| POLR3E, SDR42E2, UQCRC2, VWA3A, CDR2, EEF2K, MOSMO, PDZD9 | | Chromosome 16p12.1 deletion syndrome, 520kb | Pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21943463-22702769
| CDR2, EEF2K, MOSMO, NPIPB5, PDZD9, POLR3E, SDR42E2, UQCRC2, VWA3A | | Chromosome 16p12.1 deletion syndrome, 520kb | Likely pathogenic (Nov 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:21884192-22288219
| SDR42E2, EEF2K, MOSMO, PDZD9, UQCRC2, VWA3A | | Chromosome 16p12.1 deletion syndrome, 520kb | Pathogenic (Nov 1, 2018) | criteria provided, single submitter |